GeneGo to Combine Existing Solutions To Create ‘MetaMiner’ for Cystic Fibrosis | GenomeWeb
GeneGo said this week that it is collaborating with the Cystic Fibrosis Foundation to develop a disease-specific software package called MetaMiner — the first of a line of disease-focused analysis products that the company has in the works.
The new package, MetaMiner (CF), will include GeneGo’s existing MetaDrug, MetaCore, MetaLink, and MapEditor packages, but will also contain “omics” data and other information that is specific to cystic fibrosis.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.